+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06928506

RECLAIM Study Evaluating Hi-OxSR and Hi-Ox Devices for Treating Post COVID Cognitive Dysfunction with Adaptive Integrative Medicine

Led by University Health Network, Toronto · Updated on 2026-10-22

120

Participants Needed

3

Research Sites

60 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether the Hi-OxSR device can improve symptoms of post COVID cognitive dysfunction, a condition affecting people with lingering effects after COVID-19 infection. This study builds on earlier findings showing that carbon dioxide, delivered via the Hi-OxSR device, may have antioxidant and anti-inflammatory benefits. It aims to find the best treatment dose and assess the safety of using this device in affected patients. Participants will be randomly assigned to one of three groups using the Hi-OxSR device twice daily for 30 minutes at low oxygen flow for 2 weeks, the same treatment for 4 weeks, or using the Hi-Ox device without CO2 rebreathing twice daily for 30 minutes at high oxygen flow for 2 weeks. The Hi-OxSR device is designed to deliver rebreathed exhaled breath with added oxygen, while the Hi-Ox device delivers oxygen only. During the study, participants will complete cognitive tests and questionnaires measuring brain fog, fatigue, mental health, and quality of life at several points up to six months. Blood samples will also be collected. Researchers will monitor safety and adverse events throughout. The study starts with a screening period and continues with treatment and follow-up assessments lasting up to six months to evaluate changes in cognitive function and symptoms.

CONDITIONS

Brief Title

Effect of Hi-OxSR for the Treatment of Post COVID Condition

Research Team

S

suzanne Cohen

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here